Document is current
Any future updates will be listed below
-
Authors
Morales-Campos, Daisy Y.
Adsul, Prajakta
Liang, Yuanyuan
Donovan, Erin
Moczygemba, Leticia R.
Kahn, Jessica A.
-
Funding
Funding for this research was provided by:
The National Cancer Institute, Division of Cancer Control and Population Sciences (R01 CA272757, R01 CA272757, R01 CA272757, R01 CA272757, R01 CA272757, R01 CA272757)
- License Information
-
More Information
Article History
Received: 1 March 2025
Accepted: 10 March 2025
First Online: 9 April 2025
Declarations
:
: This study is approved by the UTHealth Houston IRB for all participating sites (HSC-SPH-24-0335, Version 1.0, August 14, 2024) and registered in ClinicalTrials.gov (NCT06598475). We developed consent forms in English for provider and staff surveys and implementation team interviews, and English and Spanish for parent interviews (see Supplemental Files 4-7). Research staff will obtain informed consent before pre-post surveys and interviews, document consent in REDCap, and send participants a copy of the consent form via email. We will aggregate data on any reports, presentations or publications reporting results from this study. After the entire study is completed, the PI will destroy any all identifying contact information. All study databases will be de-identified and archived at UTHealth Houston. We will carry out all methods in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.
